相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis
Tetsuya Furukawa et al.
MODERN RHEUMATOLOGY (2019)
Inflammatory marker YKL-40 levels in intrahepatic cholestasis of pregnancy
Ilkbal Temel Yuksel et al.
GYNECOLOGICAL ENDOCRINOLOGY (2019)
Chitinase-3-like Protein 1 (YKL-40) Is Expressed in Lesional Skin in Hidradenitis Suppurativa
Joanna Salomon et al.
IN VIVO (2019)
Serum YKL-40 in patients with psoriasis vulgaris treated by narrow-band UVB phototherapy
Mohammed Abu El-Hamd et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2019)
Serum YKL-40 as a potential biomarker of inflammation in psoriasis
Anna Baran et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2018)
Angiogenic potential of YKL-40 in the dynamics of tumor niche
Ayda Pouyafar et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
YKL-40: A biomarker for early nephropathy in type 2 diabetic patients and its association with inflammatory cytokines
Dhamodharan Umapathy et al.
IMMUNOBIOLOGY (2018)
Chitinase 3 like 1 (CHI3L1) promotes vasculogenic mimicry formation in cervical cancer
Nipaporn Ngernyuang et al.
PATHOLOGY (2018)
Anti-endothelial cell antibodies do not correlate with disease activity in systemic sclerosis
Malgorzata Michalska-Jakubus et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2018)
Chitinase-3-like protein 1 (YKL-40) is a biomarker of severity of joint involvement in psoriatic arthritis
Joanna Salomon et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2018)
Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation studies based on the CIMESTRA and OPERA trials
C. H. Brahe et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2018)
The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review
Xiang Tong et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Chitinase-3-like Protein 1 (YKL-40) Expression in Squamous Cell Skin Cancer
Joanna Salomon et al.
ANTICANCER RESEARCH (2018)
The antifibrotic drug pirfenidone inhibits spondyloarthritis fibroblast-like synoviocytes and osteoblasts in vitro
Julie Stougaard et al.
BMC RHEUMATOLOGY (2018)
Obesity, Type 1 Diabetes, and Psoriasis: An Autoimmune Triple Flip
Mariagrazia Granata et al.
PATHOBIOLOGY (2017)
Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment
Stephen Chu-Sung Hu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis
Joanna Salomon et al.
MEDIATORS OF INFLAMMATION (2017)
Psoriasis Patients Treated With Biologics and Methotrexate Have a Reduced Rate of Myocardial Infarction: A Collaborative Analysis Using International Cohorts
Wayne P. Gulliver et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2016)
Cardiovascular risk in patients with psoriatic arthritis
T. V. Korotaeva et al.
TERAPEVTICHESKII ARKHIV (2016)
Selected Inflammatory and Metabolic Markers in Psoriatic Patients Treated with Goeckerman Therapy
Katerina Kondelkova et al.
MEDIATORS OF INFLAMMATION (2015)
Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?
Gamze Erfan et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity
Lihi Eder et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Adiponectin levels in patients with psoriasis: A meta-analysis
Kun-Ju Zhu et al.
JOURNAL OF DERMATOLOGY (2013)
YKL-40 is a serum biomarker reflecting the severity of cutaneous lesions in psoriatic arthritis
Yasutomo Imai et al.
JOURNAL OF DERMATOLOGY (2013)
Plasma YKL-40: a potential biomarker for psoriatic arthritis?
P. Jensen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management
Anna Russolillo et al.
RHEUMATOLOGY (2013)
Obesity and the prediction of minimal disease activity: A prospective study in psoriatic arthritis
Matteo Nicola Dario di Minno et al.
ARTHRITIS CARE & RESEARCH (2013)
Psoriasis and metabolic syndrome
Hidetoshi Takahashi et al.
JOURNAL OF DERMATOLOGY (2012)
Assessing joint involvement in haemophilia by clinical rheumatologic scores. A pilot study on similarities with subjects with psoriatic arthritis
Matteo Nicola Dario Di Minno et al.
CLINICAL RHEUMATOLOGY (2011)
YKL-40 (chitinase 3-like-1) as a biomarker for psoriasis vulgaris and pustular psoriasis
Yasutomo Imai et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2011)
Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors
Susanne Juhl Pedersen et al.
CLINICAL RHEUMATOLOGY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis
Paolo Gisondi et al.
JOURNAL OF HEPATOLOGY (2009)
Psoriasis patients show signs of insulin resistance
S. Boehncke et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
YKL-46 as a marker of joint involvement in inflammatory bowel disease
D Bernardi et al.
CLINICAL CHEMISTRY (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
分享论文
